During the past decade, Centre Pierre Curie conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 1 clinical trials were completed, i.e. on average, 9.1% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Pierre Curie" #1 sponsor was "Federation Francophone de Cancerologie Digestive" with 5 trials, followed by "Centre Oscar Lambret" with 4 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Centre Francois Baclesse" with 1 trials sponsored and "Centre Hospitalier Universitaire, Amiens" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Pierre Curie" #1 collaborator was "GERCOR - Multidisciplinary Oncology Cooperative Group" with 2 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Association de Neuro-Oncologues d'Expression Francaise" with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator and "Centre de traitement des données du Cancéropôle Nord-Ouest, Centre F. BACLESSE, Caen, France" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Centre Pierre Curie" are "Breast Cancer" (4 trials), "Colorectal Cancer" (3 trials), "Cancer" (2 trials), "All Tumor Types" (1 trials) and "COVID" (1 trials). Many other conditions were trialed in "Centre Pierre Curie" in a lesser frequency.

Most popular intervention types in "Centre Pierre Curie" are "Drug" (9 trials), "Behavioral" (2 trials), "Biological" (1 trials), "Dietary Supplement" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel" (3 trials), "Bevacizumab" (2 trials), "5 FU bolus" (1 trials), "5 FU continuous" (1 trials) and "5Fluorouracil bolus" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre Pierre Curie" are 10 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Centre Pierre Curie". undefined are not yet recruiting, 6 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Centre Pierre Curie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centre Pierre Curie, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".